
Sign up to save your podcasts
Or


Today’s episode was about Project Optimus, the FDA initiative to improve dose selection and optimization for oncology products. Julie Bullock was a guest on this episode and shared her expertise as a former oncology clinical pharmacology reviewer at the FDA and as a current consultant in the pharmaceutical industry.
Links discussed in the show:
Copyright Teuscher Solutions LLC
All Rights Reserved
By Nathan Teuscher5
2828 ratings
Today’s episode was about Project Optimus, the FDA initiative to improve dose selection and optimization for oncology products. Julie Bullock was a guest on this episode and shared her expertise as a former oncology clinical pharmacology reviewer at the FDA and as a current consultant in the pharmaceutical industry.
Links discussed in the show:
Copyright Teuscher Solutions LLC
All Rights Reserved

9,514 Listeners

112,105 Listeners

56,649 Listeners

9,543 Listeners

34 Listeners